Private equity groups have displayed significant interest in cardiology over the last several years as the specialty sees a rise in outpatient growth and demand for cardiovascular services remains high among U.S. patients.
In January, PE Hub reported on several PE-backed deals over the last two years that have shaped consolidation in cardiology:
1. RTI Surgical and Collagen Solutions: Alachua, Fla.-based RTI Surgical, a contract development and management organization focused on regenerative medicine, acquired Eden Prairie, Minn.-based Collagen Solutions in October 2024. Collagen Solutions produces medical-grade collagen and xenograft tissue for cardiac applications. RTI Surgical was acquired in 2020 by London-based Montagu Private Equity.
2. IK Partners invests in Defibrion: In July 2024, London-based PE firm IK Partners announced it had acquired a stake in Defibrion, a distributor of automated external defibrillators, from existing shareholders.
3. WindRose Health Investors acquires CardioOne: In March 2024, WindRose Health Investors, a New York City-based PE firm, completed its acquisition of CardioOne, a physician-aligned, cardiology-focused management services organization that supports independent cardiology practices.
4. Pharos Capital acquires RhythMedix: In January 2024, Dallas- and Nashville, Tenn.-based Pharos Capital acquired RhythMedix, a cardiac monitoring systems maker based in Mount Laurel, N.J.
